Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-03-08

Clinical Trial Update: Testing of a Functional Outcome Measure for Those With Visual Field Defects

View source ↗

Summary

A clinical trial evaluating a functional outcome measure for individuals with visual field loss due to homonymous hemianopia has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: NovaVision, Inc. | Conditions: Hemianopsia, Homonymous | Status: SUSPENDED